Home > Healthcare > Medical Devices > Therapeutic Devices > Pneumatic Nebulizers Market
Pneumatic Nebulizers Market Size
Pneumatic Nebulizers Market size exceeded USD 557.7 million in 2020 and is anticipated to grow at over 5.2% CAGR between 2021 and 2027. The rising pervasiveness of asthma and chronic obstructive pulmonary disease will foster the market growth during the forecast timeline. The increasing incidence of respiratory defects is attributable to the growing global air pollution will further fuel the market expansion. Moreover, the growing geriatric population base across the world will spur the market value in the coming years.
The spread of the COVID-19 pandemic across the globe has positively impacted market in 2020. The medical device market witnessed a sudden spike in the sales of pneumatic nebulizers during pandemic. The outbreak of COVID-19 pandemic highlighted the need for aerosol-generating procedures such as nebulizers for the treatment of respiratory disorders and infection such as asthma, SARS-CoV-2 and others. Home-based COVID infected patients used nebulizers to get relief from the symptoms of infection. The demand barbed as the number of infection rate increased and high adoption of home-based treatment.
| Report Attributes | Details |
|---|---|
| Base Year: | 2020 |
| Market Size in 2020: | 557.7 Million (USD) |
| Forecast Period: | 2021 to 2027 |
| Forecast Period 2021 to 2027 CAGR: | 5.2% |
| 2027 Value Projection: | 789.9 Million (USD) |
| Historical Data for: | 2016 to 2020 |
| No. of Pages: | 150 |
| Tables, Charts & Figures: | 159 |
| Segments covered: | Product and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Pneumatic Nebulizers Market Trends
The rising prevalence of asthma and COPD (chronic obstructive pulmonary disease) diseases will propel the industry growth. According to the World Health Organization, in 2019, around 262 million people suffered from asthma and it resulted in 4,61,000 deaths globally. The treatment of asthma and COPD is long-term may result in high healthcare expenditure. Furthermore, rising urbanization, declining quality of air, and high awareness regarding respiratory disease and treatment will further stimulate the demand for pneumatic nebulizers in the industry.
Risk of infection due to the nebulizers will slow down the market progression
The American Society of Microbiology (ASM) stated that regular use of pneumatic nebulizers at home setting will increase the risks of bacterial infection. The pneumatic nebulizers devices may host the growth of pathogens like Rhizobium, Stenotrophomonas, Staphylococcus, and Streptococcus. This has been negatively impacting the market and will continue to restrain the industry expansion in the coming years. Additionally, lower insurance coverage scenarios in developing economies will further restrict the industry value during the forecast period.
Pneumatic Nebulizers Market Analysis
Breath actuated segment was valued at USD 338 million in 2020. The increasing prevalence of asthma, COPD and coronavirus infection in the geriatric population will impel the demand for pneumatic nebulizers products and drive the industry progression. Geriatric population experience various respiratory disorders such as emphysema, chronic obstructive pulmonary disease, asthma, lower respiratory infections and pulmonary hypertension. Treatment of these morbidities require inhaled therapies for that nebulizers are primary required. In addition, rising incidences of respiratory diseases and infection through the world will further boost the demand for pneumatic nebulizers in the industry.
North America pneumatic nebulizers market is expected to showcase over 4.8% growth rate through 2027 led by the growing incidence and prevalence of asthma among the population. According to Asthma and Allergy Foundation of America (AAFA), more than 25 million American people suffer from asthma which equals to one in thirteen American people. The asthma prevalence rate in children is also increasing, around 44.3% of American children (under 18 years old) has asthma. In North America, asthma is more common in adult women than men. The high prevalence of asthma will enhance the demand for aerosol therapy, thereby influencing the industry demand of pneumatic nebulizers over the forecast timeframe.
Pneumatic Nebulizers Market Share
A few key companies operating in the market are
- Aerogen Limited
- Allied Healthcare Products, Inc.
- Briggs Healthcare
- Becton
- Dickinson and Company
- Heyer Medical AG
- OMRON Corporation
- PARI Medical Holdings GmbH
- Philips Respironics, Inc.
- Salter Labs
- TaiDoc Technology
These market leaders are focusing on numerous strategies such as acquisitions, mergers, partnerships, new product launches, and collaborations to increase their revenue share for pneumatic nebulizers.
The pneumatic nebulizers market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:
Click here to Buy Section of this Report
Market, By Product
- Vented pneumatic nebulizers
- Table-top
- Portable
- Breath-actuated pneumatic nebulizers
- Table-top
- Portable
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Asia Pacific
- China
- India
- Japan
- Australia
- Latin America
- Brazil
- Mexico
- Middle East and Africa
- South Africa
- Saudi Arabia
Frequently Asked Questions (FAQ) :